Top Buy
| Security | Buy | Sell | Buy (1M) ▲ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Pacira Pharmaceuticals | 18 | 0 | 3 | 0 | €26.80 | €47.53 | 77.343% |
| Adverum Biotechnologies Inc. | 7 | 0 | 3 | 0 | €1.38 | €5.60 | 305.913% |
| Cara Therapeutics Inc. | 11 | 1 | 3 | 0 | €0.62 | €4.62 | 650.772% |
| Heron Therapeutics Inc. | 11 | 1 | 3 | 0 | €3.14 | €4.59 | 46.333% |
| Sutro Biopharma Inc | 21 | 0 | 3 | 0 | €3.82 | €11.04 | 189.068% |
| Exelixis Inc. | 18 | 0 | 3 | 0 | €18.72 | €26.01 | 38.960% |
| Halozyme Therapeutics Inc. | 15 | 0 | 3 | 0 | €39.67 | €47.17 | 18.906% |
| AnaptysBio Inc | 8 | 1 | 3 | 0 | €21.80 | €45.21 | 107.385% |
| Viking Therapeutics Inc | 5 | 0 | 3 | 0 | €60.20 | €100.00 | 66.113% |
| Twist Bioscience Corp | 7 | 0 | 3 | 0 | €39.06 | €41.41 | 6.014% |
| PTC Therapeutics Inc. | 15 | 8 | 3 | 3 | €33.80 | €41.51 | 22.818% |
| EyePoint Pharmaceuticals Inc. | 18 | 1 | 4 | 0 | €10.26 | €27.80 | 170.994% |
| United Therapeutics | 19 | 0 | 4 | 0 | €247.80 | €287.40 | 15.981% |
| AbbVie Inc. | 22 | 0 | 4 | 0 | €143.02 | €175.11 | 22.438% |
| Evolus Inc | 10 | 0 | 4 | 0 | €11.10 | €20.46 | 84.344% |
| MacroGenics Inc. | 13 | 0 | 4 | 0 | €3.98 | €12.42 | 212.022% |
| Amgen Inc. | 25 | 0 | 4 | 0 | €276.45 | €296.16 | 7.128% |
| Verastem Inc. | 12 | 0 | 4 | 0 | €3.72 | €20.00 | 437.634% |
| Eli Lilly Corp. | 49 | 0 | 6 | 0 | €743.60 | €776.16 | 4.379% |
| Novavax Inc. | 8 | 1 | 6 | 0 | €14.29 | €27.38 | 91.660% |
| Insmed Inc. | 19 | 2 | 6 | 2 | €20.20 | €45.11 | 123.314% |
| Neurocrine Bioscience | 30 | 0 | 7 | 0 | €129.35 | €140.87 | 8.904% |
| Biogen Inc. | 49 | 1 | 7 | 0 | €201.40 | €293.57 | 45.766% |
| G1 Therapeutics | 20 | 1 | 7 | 0 | €3.14 | €10.05 | 220.599% |
| Vertex Pharmaceuticals Inc. | 47 | 2 | 7 | 0 | €411.65 | €416.05 | 1.069% |